ALung Technologies, Inc. is proud to be a part of LivaNova. ALung developed the Hemolung for treating patients with acute respiratory failure. The Hemolung provides a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung allows the patient’s lungs to rest and heal.
View Top Employees from • ALung Technologies, now a part of LivaNovaWebsite | http://www.hemolung.com |
Revenue | $7 million |
Funding | $134.3 million |
Employees | 29 (29 on RocketReach) |
Founded | 1997 |
Address | 2500 Jane St Ste 1, Pittsburgh, Pennsylvania 15221, US |
Phone | (412) 697-3370 |
Fax | (412) 697-3376 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Category | Medical Devices, Retail, Biotechnology, Science and Engineering, Critical Care Medicine, Medical Device, Intensive Care Medicine, Health Care, Therapeutics |
Web Rank | 12 Million |
Keywords | alung, respiratory dialisis |
Competitors | Atc Technologies Inc, Bacchus Vascular, Biometrix, Remon Medical Technologies, Tracoe Medical GmbH |
SIC | 384, 38 |
NAICS | 42345, 4234, 423, 42, 33 |
Looking for a particular • ALung Technologies, now a part of LivaNova employee's phone or email?
The • ALung Technologies, now a part of LivaNova annual revenue was $7 million in 2023.
Pete DeComo is the Chairman and Chief Executive Officer of • ALung Technologies, now a part of LivaNova.
29 people are employed at • ALung Technologies, now a part of LivaNova.
• ALung Technologies, now a part of LivaNova is based in Pittsburgh, Pennsylvania.
The NAICS codes for • ALung Technologies, now a part of LivaNova are [42345, 4234, 423, 42, 33].
The SIC codes for • ALung Technologies, now a part of LivaNova are [384, 38].